GNVR logo

Genvor IncorporatedOTCPK:GNVR Stock Report

Market Cap US$15.6m
Share Price
n/a
1Yn/a
7D-13.8%
1D-13.8%
Portfolio Value
​
View

Genvor Incorporated

OTCPK:GNVR Stock Report

Market Cap: US$15.6m

Genvor (GNVR) Stock Overview

Develops plant-based defense technology designed to help farmers achieve global food security. More details

GNVR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Makes less than USD$1m in revenue ($0)

Earnings have declined by 1.6% per year over past 5 years

Negative shareholders equity

Shares are highly illiquid

+ 2 more risks

GNVR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW499,625 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
499,625 investors already sharing narratives
View all narratives

Genvor Incorporated Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genvor
Historical stock prices
Current Share PriceUS$0.43
52 Week HighUS$3.00
52 Week LowUS$0.014
Beta537517.4
1 Month Change7.71%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-89.23%

Recent News & Updates

Recent updates

Shareholder Returns

GNVRUS BiotechsUS Market
7D-13.8%2.3%0.8%
1Yn/a42.3%20.2%

Return vs Industry: Insufficient data to determine how GNVR performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how GNVR performed against the US Market.

Price Volatility

Is GNVR's price volatile compared to industry and market?
GNVR volatility
GNVR Average Weekly Movementn/a
Biotechs Industry Average Movement10.3%
Market Average Movement7.3%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.2%

Stable Share Price: GNVR's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GNVR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5Chad Pawlakwww.genvor.com

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization.

Genvor Incorporated Fundamentals Summary

How do Genvor's earnings and revenue compare to its market cap?
GNVR fundamental statistics
Market capUS$15.60m
Earnings (TTM)-US$1.29m
Revenue (TTM)n/a
0.0x
P/S Ratio
-12.0x
P/E Ratio

Is GNVR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GNVR income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$1.29m
Earnings-US$1.29m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.036
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-18.5%

How did GNVR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 10:45
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genvor Incorporated is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.